Skip to main content

Pioglitazone Hydrochloride

Therapy Area
Anti-Diabetic
API Technology
Synthetic
Formulation
Oral Solids
Development Status
Available
Available Regulatory Filing
USA
CEP
Europe
Australia
New Zealand
China
Japan
Saudi Arabia
Turkey
Innovator Brand (US)
ACTOS

We are here to help, if you have any country specific requirements - please Contact Us.